United Therapeutics | UTHR - Interest Income


United Therapeutics reported $43.2M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Amarin USD 3.37M 3.37M Dec/2024
Baxter International USD 12M 1000K Mar/2026
Bayer EUR 169M 39M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.27 0.13 Jun/2026
Moderna USD 72M 2M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sarepta Therapeutics USD 8.74M 359K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026